1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Edgemont Pharmaceuticals, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD) Extended-release lorazepam, Placebo - Generalized Anxiety Disorder (GAD) | Phase 3 | Completed | Edgemont Pharmaceuticals, LLC | 495 | 2015-01-01 | 2018-09-26 |
Generalized Anxiety Disorder (1)
United States (1)